Evidence map›Paper›PMID 40802429›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2025

Follow-up evaluation of long COVID syndrome in patients with SARS-CoV-2 infection.

Sezin Hoşgel Sevdimbaş, Ayşe Seza İnal, Ferit Kuşcu, Behice Kurtaran, Aslıhan Candevir, Yeşim Taşova, Süheyla Kömür

Abstract read
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sezin Hoşgel SevdimbaşUniversity of Health Sciences Adana City, Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0001-5136-2966
Ayşe Seza İnalCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0002-1182-7164
Ferit KuşcuCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0001-5662-8305
Behice KurtaranCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0002-2081-4664
Aslıhan CandevirCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0001-9340-516X
Yeşim TaşovaCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0002-5728-058X
Süheyla KömürCukurova University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.ORCID http://orcid.org/0000-0003-2414-559X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong COVID, which refers to persistent symptoms following acute COVID-19, is being increasingly reported. However, available data regarding its prevalence and characteristics are limited. This study was conducted to evaluate the occurrence and presentation of long COVID in patients with COVID-19 who were followed up in outpatient, ward, or intensive care settings.

methodsThis study included patients who were diagnosed with COVID-19 at least four weeks prior to the start of the study. The patients underwent symptom assessment at baseline and 1, 3, 6, and 12 months post-infection. Functional status was evaluated using the Post-COVID-19 Functional Status (PCFS) Scale, and quality of life was assessed using the SF-36 Health Survey questionnaire.

resultsA total of 134 patients (71 males [54.2%]), with a mean age of 43.7 (15.3) years, participated in this study. The distribution of patients across care settings was as follows: 51.1% outpatients, 35.9% in wards, and 13% in intensive care units (ICUs). Fatigue during exertion was the most frequently reported long COVID symptom. Patients treated in ICUs experienced a higher burden of long COVID symptoms than those treated in outpatient or ward settings. Furthermore, patients treated in ICUs and wards had a significantly poorer quality of life and functional status than the outpatients.

conclusionsLong COVID poses a significant ongoing health concern, particularly for patients who require intensive care during acute COVID-19. Vigilant monitoring of long-term sequelae, particularly those that affect quality of life and functional status, is crucial for individuals recovering from COVID-19.

Indexed as

COVID-19AdultAgedFemaleFollow-Up StudiesHumansIntensive Care UnitsMaleMiddle AgedPost-Acute COVID-19 SyndromeQuality of LifeSARS-CoV-2

Identifiers

PMID40802429
PMCPMC12333617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.